Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Cancers
|
January 27, 2021
Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
Anne Gomez-Brouchet, Julia Gilhodes, Nathalie Van Acker, et al.
Nature
|
July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancers
François Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature
|
May 24, 2019
Genomic characterization of metastatic breast cancers
François Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
International Journal of Cancer
|
October 17, 2022
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France
Victoria Corvest, Perrine Marec-Bérard, Cyril Lervat, et al.
Scientific Reports
|
December 19, 2023
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity
Grégoire Marret, Stéphane Temam, Maud Kamal, et al.
Multidisciplinary Respiratory Medicine
|
September 28, 2020
High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19
Carolina Panadero, Araceli Abad-Fernández, Mª Teresa Rio-Ramirez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.
Nature Medicine
|
January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial
Thomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Nature Medicine
|
July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial
Fernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Heart Failure Reviews
|
April 16, 2026
Voice recognition as an innovative method to identify and monitor heart failure - a review
Amy S Fuller, Nduka C Okwose, Sarah J Charman, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Cancers
|
January 27, 2021
Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
Anne Gomez-Brouchet, Julia Gilhodes, Nathalie Van Acker, et al.
Nature
|
July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancers
François Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature
|
May 24, 2019
Genomic characterization of metastatic breast cancers
François Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
International Journal of Cancer
|
October 17, 2022
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France
Victoria Corvest, Perrine Marec-Bérard, Cyril Lervat, et al.
Scientific Reports
|
December 19, 2023
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity
Grégoire Marret, Stéphane Temam, Maud Kamal, et al.
Multidisciplinary Respiratory Medicine
|
September 28, 2020
High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19
Carolina Panadero, Araceli Abad-Fernández, Mª Teresa Rio-Ramirez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.
Nature Medicine
|
January 19, 2021
Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial
Thomas Bachelot, Thomas Filleron, Ivan Bieche, et al.
Nature Medicine
|
July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial
Fernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Heart Failure Reviews
|
April 16, 2026
Voice recognition as an innovative method to identify and monitor heart failure - a review
Amy S Fuller, Nduka C Okwose, Sarah J Charman, et al.
Page
of 8